Find and explore trending articles from around the web in a clutter-free reading mode.
livemint.com • Pharmaceuticals • India
Indian drugmakers Natco Pharma and Dr Reddy's are suing Novo Nordisk over its blockbuster anti-obesity drug, semaglutide, aiming to launch cheaper generic versions before the patent expires, fueled by the lucrative Indian market.